Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.046 AUD | -11.54% |
|
-8.00% | -23.33% |
25/02 | Bio-Gene Technology Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
19/01 | Bio-gene Technology Secures R&D Tax Rebate for Fiscal Year 2023 | MT |
Business Summary
Sales per Business
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
License Fees
100.0
%
| - | - | 0 | 100.0 % | - |
Sales per region
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Australia
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -66.52% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Tim Grogan
CEO | Chief Executive Officer | - | 28/23/28 |
Peter May
CTO | Chief Tech/Sci/R&D Officer | - | - |
Sarah Driessens
LAW | General Counsel | - | 01/22/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Peter May
CTO | Chief Tech/Sci/R&D Officer | - | - |
Andrew Guthrie
BRD | Director/Board Member | - | 26/21/26 |
Alex Ding
CHM | Chairman | - | 12/23/12 |
Director/Board Member | - | 12/23/12 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 201,361,570 | 112,629,198 ( 55.93 %) | 0 | 55.93 % |
Company contact information
![address Bio-Gene Technology Limited(BGT)](https://cdn.zonebourse.com/static/address/38123488.png)
Sales per Business
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-23.33% | 6.98M | |
+8.79% | 36.17B | |
-.--% | 12.3B | |
+35.31% | 7.05B | |
-11.77% | 6.93B | |
+7.54% | 6.63B | |
-10.07% | 5.75B | |
-11.62% | 5.19B | |
+30.00% | 5.13B | |
-3.17% | 5.01B |
- Stock Market
- Equities
- BGT Stock
- Company Bio-Gene Technology Limited